IMRT/VMAT dosimetric verification historically was performed in a phantom replacing a patient on the treatment table. Ideally this should be a full volumetric measurement, but in practice only a limited number of points is typically sampled. The usual metric to quantify agreement with the TPS is the gamma index which combines dose-error and distance to agreement analysis components. While γ-analysis is intuitively appropriate for the commissioning process, its value for per-patient QA is not so obvious. It was shown that the correlation between the γ pass/fail rates and clinically relevant patient DVH deviations is weak and counter-intuitive.
The 3DVH software package (Sun Nuclear Corp., Melbourne, FL) attempts to bridge this gap by using experimental data acquired during a single irradiation of a cylindrical diode array (ArcCHECK) to accomplish both the traditional γ-analysis on a phantom, and the measurementguided dose reconstruction (MGDR) on an arbitrary patient dataset. After the ArcCHECK irradiation, the time resolved (50 ms) dose data are synchronized with the absolute delivery time through a virtual inclinometer. Subsequently, the arc is discretized into sub-beams synchronized in time with the RT Plan control points (CP). Relative dose grids on the phantom per sub-beam are calculated with a convolution-type algorithm customized for the cylindrical phantom. These relative dose grids are morphed into absolute by using the measured exit and entrance diode doses seen by each beamlet. Upon summation, the volumetric, dense dose grid on the phantom is known. Using these data to estimate the dose delivered to the patient is strikingly simple (Fig). The ratio of the MGDR to the TPS dose is determined for each voxel on the cylindrical phantom. This ratio serves as a correction factor for the corresponding TPS voxel doses on the patient dataset. When the TPS dose per CP is known, the processing order can be modified: the correction factors are determined on the sub-beam level and applied to the patient TPS dose accordingly. As a result, estimated volumetric dose on a patient is known as a function of time (4D). The time-stamped volumetric dose grids can be saved as RT Dose objects, providing the natural framework for "virtual motion studies". The method is easy to validate because in principle the MGDR results can be compared to any dosimeter in any phantom. We chose traditional ion chamber and film combination on a cubic phantom. Good agreement was observed for the TG-119-type plans: 0.0±0.9% average PTV point dose error and 96% average film γ(2%/2mm) passing rate. Average straight dose difference between film and MGDR is less than 1% on all but one film. For the 4D part, time resolved MGDR point doses were compared to the ion chamber with the accumulated dose recorded every 100 ms. Also, accumulated time-resolved MGDR dose at the end of treatment was compared to the composite MGDR dose which was shown earlier in this study to agree well with the independent measurements in the "patient".
